Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Sonova Audiological Care Denmark ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading... Loading... Loading... Loading...

1.0 Bankruptcy Risk  2018 2019/3 2019 2020/3 2020 2021/3 2021 2022/3 2022 2023/3 2023 2024/3 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 3.6% 3.6%   Bankruptcy risk   8.8% 5.0% 2.3% 9.6% 3.9% 1.5% 4.2% 4.1%   Credit score (0-100)   29 45 64 24 50 74 48 49   Credit rating   BB BBB BBB BB BBB A BBB BBB   Credit limit (mDKK)   0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1.0 Income statement (mDKK)  2018 2019/3 2019 2020/3 2020 2021/3 2021 2022/3 2022 2023/3 2023 2024/3 2024e N/A 2025e N/A Net sales   184 199 187 175 200 223 223 223   Gross profit   68.3 75.4 89.1 56.6 62.9 88.9 0.0 0.0   EBITDA   -17.2 -2.4 5.4 -25.6 -17.2 1.1 0.0 0.0   EBIT   -17.2 -2.4 5.4 -25.6 -26.5 -8.3 0.0 0.0   Pre-tax profit (PTP)   -17.8 -3.8 6.5 -26.4 -27.2 -9.8 0.0 0.0   Net earnings   -17.8 -3.8 6.5 -26.4 -29.7 -6.6 0.0 0.0   Pre-tax profit without non-rec. items   -17.2 -2.4 5.4 -25.6 -27.2 -9.8 0.0 0.0     See the entire income statement 1.0 Balance sheet (mDKK)  2018 2019/3 2019 2020/3 2020 2021/3 2021 2022/3 2022 2023/3 2023 2024/3 2024e N/A 2025e N/A Tangible assets total   0.0 0.0 0.0 0.0 16.6 16.9 0.0 0.0   Shareholders equity total   10.5 28.6 35.1 14.7 15.0 47.2 46.7 46.7   Interest-bearing liabilities   0.0 0.0 0.0 0.0 26.6 4.8 0.0 0.0   Balance sheet total (assets)   102 106 105 85.7 85.5 98.8 46.7 46.7   Net Debt   0.0 0.0 0.0 0.0 25.3 2.9 -33.0 -33.0     See the entire balance sheet 1.0 Volume  2018 2019/3 2019 2020/3 2020 2021/3 2021 2022/3 2022 2023/3 2023 2024/3 2024e N/A 2025e N/A Net sales   184 199 187 175 200 223 223 223   Net sales growth   12.5% 7.7% -6.1% -6.2% 14.4% 11.5% 0.0% 0.0%   Gross profit   68.3 75.4 89.1 56.6 62.9 88.9 0.0 0.0   Gross profit growth   10.8% 10.4% 18.1% -36.5% 11.1% 41.4% -100.0% 0.0%   Employees   159 162 162 158 165 170 0 0   Employee growth %   0.0% 1.9% 0.0% -2.5% 4.4% 3.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   102 106 105 86 85 99 47 47   Balance sheet change%   23.2% 3.0% -0.3% -18.5% -0.2% 15.6% -52.7% 0.0%   Added value   -17.2 -2.4 5.4 -25.6 -26.5 1.1 0.0 0.0   Added value %   -9.3% -1.2% 2.9% -14.6% -13.2% 0.5% 0.0% 0.0%   Investments   -50 0 0 0 25 -13 -17 0   Net sales trend   1.0 2.0 -1.0 -2.0 1.0 2.0 0.0 0.0   EBIT trend   -3.0 -4.0 1.0 -1.0 -2.0 -3.0 0.0 0.0   1.0 Profitability  2018 2019/3 2019 2020/3 2020 2021/3 2021 2022/3 2022 2023/3 2023 2024/3 2024e N/A 2025e N/A EBITDA %   -9.3% -1.2% 2.9% -14.6% -8.6% 0.5% 0.0% 0.0%   EBIT %   -9.3% -1.2% 2.9% -14.6% -13.2% -3.7% 0.0% 0.0%   EBIT to gross profit (%)   -25.2% -3.1% 6.1% -45.3% -42.2% -9.4% 0.0% 0.0%   Net Earnings %   -9.6% -1.9% 3.5% -15.1% -14.9% -2.9% 0.0% 0.0%   Profit before depreciation and extraordinary items %   -9.6% -1.9% 3.5% -15.1% -10.2% 1.3% 0.0% 0.0%   Pre tax profit less extraordinaries %   -9.3% -1.2% 2.9% -14.6% -13.6% -4.4% 0.0% 0.0%   ROA %   -18.5% -2.3% 5.2% -26.9% -31.0% -9.0% 0.0% 0.0%   ROI %   -24.8% -2.3% 5.2% -26.9% -41.1% -17.1% 0.0% 0.0%   ROE %   -258.8% -19.6% 20.4% -106.2% -200.5% -21.1% 0.0% 0.0%   1.0 Solidity  2018 2019/3 2019 2020/3 2020 2021/3 2021 2022/3 2022 2023/3 2023 2024/3 2024e N/A 2025e N/A Equity ratio %   100.0% 100.0% 100.0% 100.0% 17.5% 47.8% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 34.4% 22.3% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 33.7% 21.4% -14.8% -14.8%   Net int. bear. debt to EBITDA, %   0.0% 0.0% 0.0% 0.0% -147.3% 263.1% 0.0% 0.0%   Gearing %   0.0% 0.0% 0.0% 0.0% 178.1% 10.2% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 0.0% 0.0% 0.0% 5.2% 9.6% 0.0% 0.0%   1.0 Liquidity  2018 2019/3 2019 2020/3 2020 2021/3 2021 2022/3 2022 2023/3 2023 2024/3 2024e N/A 2025e N/A Quick Ratio   0.0 0.0 0.0 0.0 0.4 0.9 0.0 0.0   Current Ratio   0.0 0.0 0.0 0.0 0.7 1.2 0.0 0.0   Cash and cash equivalent   0.0 0.0 0.0 0.0 1.3 1.9 0.0 0.0   1.0 Capital use efficiency  2018 2019/3 2019 2020/3 2020 2021/3 2021 2022/3 2022 2023/3 2023 2024/3 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 29.2 36.4 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 25.4 28.8 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 19.1% 19.0% 14.8% 14.8%   Net working capital   0.0 0.0 0.0 0.0 -19.0 5.6 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% -9.5% 2.5% 0.0% 0.0%   1.0 Employee efficiency  2018 2019/3 2019 2020/3 2020 2021/3 2021 2022/3 2022 2023/3 2023 2024/3 2024e N/A 2025e N/A Net sales / employee   1 1 1 1 1 1 0 0   Added value / employee   -0 -0 0 -0 -0 0 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   -0 -0 0 -0 -0 0 0 0   EBIT / employee   -0 -0 0 -0 -0 -0 0 0   Net earnings / employee   -0 -0 0 -0 -0 -0 0 0